# EDWARDS INTUITY Valve System CADENCE Study

Study · id `cardio:ct-nct02688153` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02688153](<https://clinicaltrials.gov/study/NCT02688153>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02688153

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT02688153. Randomized; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2016-04 (actual). Results posted on 2018-06-01.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT02688153, source copy `cardio:ctgov-nct02688153-2018-06-01`, retrieved 2026-10-26)
- Start date: 2012-10 (registry gives no type) (ClinicalTrials.gov record NCT02688153, source copy `cardio:ctgov-nct02688153-2018-06-01`, retrieved 2026-10-26)
- Primary completion: 2016-04 (actual) (ClinicalTrials.gov record NCT02688153, source copy `cardio:ctgov-nct02688153-2018-06-01`, retrieved 2026-10-26)
- Completion: 2016-04 (actual) (ClinicalTrials.gov record NCT02688153, source copy `cardio:ctgov-nct02688153-2018-06-01`, retrieved 2026-10-26)
- Results first posted: 2018-06-01 (ClinicalTrials.gov record NCT02688153, source copy `cardio:ctgov-nct02688153-2018-06-01`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02688153, source copy `cardio:ctgov-nct02688153-2018-06-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02688153-2018-06-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: EDWARDS INTUITY Valve System CADENCE Study
- Acronym: CADENCE
- Condition: Aortic Valve Disease
- Condition: Aortic Stenosis
- Intervention (Device): EDWARDS INTUITY
- Intervention (Device): Stented aortic bioprostheses
- Lead sponsor: Edwards Lifesciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Edwards Lifesciences (`cardio:edwards-lifesciences`)

## Provenance

Content hash: 8f171571065d43d3b80a6122ad6c42eb345d8b198910c352bd5fbdc3a1825b36
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
